Aptose Biosciences's total assets for Q2 2024 were $10.95M, a decrease of -8.35% from the previous quarter. TSE:APS total liabilities were $13.13M for the fiscal quarter, a 3.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.